SEC Filings TLDR

Wexford Capital LP, Wexford GP LLC, Charles E. Davidson, and Joseph M. Jacobs have jointly filed a Schedule 13G with the SEC, disclosing their beneficial ownership of shares in C3is Inc. As of September 22, 2025, the Reporting Persons collectively own 10.23% of the outstanding common stock of C3is Inc. The filing indic...

Lind Global Fund III LP, Lind Global Partners III LLC, and Jeff Easton have filed a Schedule 13G with the SEC, disclosing their beneficial ownership of Bionano Genomics, Inc. common stock. The filing indicates that the Reporting Persons collectively own 9.9% of the company's common stock, including shares and warrants....

This Schedule 13G filing reports the beneficial ownership of BioCardia, Inc. common stock by Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC. As of September 24, 2025, each of the reporting persons may be deemed to have beneficial ownership of 557,179 shares of common stock, representing approximately ...

Qatar Investment Authority (QIA) and Q Healthcare Holding LLC (Q Healthcare) have filed a Schedule 13G with the SEC, disclosing their beneficial ownership of shares in Alignment Healthcare, Inc. Q Healthcare, which is solely owned by QIA, directly holds 13,246,096 shares of common stock, representing 6.69% of the outst...

ForGrowth III PA B.V., Forbion Growth Opportunities Fund III Cooperatief U.A., and Forbion Growth III Management B.V. (collectively referred to as the Reporting Persons) have filed a Schedule 13G indicating beneficial ownership of 9.99% of the outstanding Common Stock of Vor Biopharma Inc. This ownership is attributed ...

Citadel Securities GP LLC, Citadel Securities LLC, Citadel Securities Group LP, Citadel Advisors LLC, Citadel Advisors Holdings LP, Citadel GP LLC, and Kenneth Griffin have jointly filed a Schedule 13G with the SEC, disclosing their beneficial ownership of shares in RH. The filing indicates that Citadel Securities LLC ...

GordonMD Global Investments LP, GordonMD Long Biased Master Fund LP, GordonMD Long Biased GP LLC, and Craig D. Gordon have jointly filed a Schedule 13G indicating their ownership of 6.2% of the Common Stock of Pyxis Oncology, Inc. The filing, dated September 23, 2025, reports that these entities collectively own 3,834,...

The William H. Miller III Living Trust filed a Schedule 13G with the SEC, disclosing its ownership of 34,051,925 shares of common stock in PRECIGEN, INC., representing 9.2% of the company's outstanding shares. The filing includes 16,666,667 shares that could be acquired within 60 days upon the exercise of warrants. The...

Tang Capital Management, LLC, along with Tang Capital Partners, LP, Tang Capital Partners International, LP, Tang Capital Partners III, Inc., Tang Capital Partners IV, Inc., and Kevin Tang, have filed a Schedule 13G with the SEC, disclosing beneficial ownership of 4,720,357 shares of PMV Pharmaceuticals, Inc. common st...

The filing is a Schedule 13G submitted by multiple entities, including IKAV General Partner s.a r.l., VEPU Inc., IDI Investment s.a r.l., IKAV SICAV-FIS SCA, SIMLOG Inc., Simlog S.a r.l., Institut fur Kapitalanlagen und Vesicherungslosungen GmbH, and Constantin von Wasserschleben. These entities have jointly filed to r...

Multiple entities, including Axislink Holding B.V., HONGKONG YUNEXPRESS LOGISTICS LIMITED, Shenzhen Qianhai Yunexpress Logistics Co., Ltd., Shenzhen YKD Technology Co., Ltd., Fujian Zongteng Network Co., Ltd., Zhoushan Juzong Investment Partnership Enterprise (Limited Partnership), and Mr. Wang Zuan, have jointly filed...

Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander have filed a Schedule 13G with the SEC, disclosing their beneficial ownership of 5.1% of the common stock of AnaptysBio, Inc. The filing, made under Rule 13d-1(c), indicates that the shares are held by entities subject to voting control...

The Schedule 13G filing reports the beneficial ownership of common stock in Tango Therapeutics, Inc. by several entities and individuals, collectively referred to as the Reporting Persons. As of September 19, 2025, Invus Public Equities, L.P. directly held 5,082,716 shares (4.6% of the total shares outstanding), and Av...

RIME VALUE ORIENTED LPF, based in Hong Kong, has reported a 9% ownership stake in Super X AI Technology Ltd through a Schedule 13G filing. The filing indicates that RIME VALUE ORIENTED LPF holds 2,680,000 ordinary shares of Super X AI Technology Ltd, with sole voting and dispositive power over these shares. The filing ...

Graham Capital Management, L.P., along with its affiliates KGT, Inc., Graham Macro Strategic Ltd., and Graham Credit Opportunities Ltd., filed a Schedule 13G with the SEC on September 22, 2025, disclosing their beneficial ownership of Class A Common Stock of Strive, Inc. The filing indicates that the reporting persons ...

On September 22, 2025, Invus Public Equities, L.P., along with its affiliates, filed a Schedule 13G with the SEC, disclosing their beneficial ownership of shares in Rezolute, Inc. Invus Public Equities directly held 4,171,401 shares, representing 4.6% of the outstanding shares, while Avicenna Life Sci Master Fund LP he...

White Lion Capital, LLC filed a Schedule 13G with the SEC, disclosing its ownership of 450,000 common shares of Reliance Global Group, Inc., representing 9.77% of the outstanding shares. The shares were acquired pursuant to a purchase agreement. The filing indicates that White Lion Capital has sole voting and dispositi...

Leviticus Partners LP has filed a Schedule 13G with the SEC, disclosing ownership of 130,000 shares of common stock in Precipio, Inc., representing 8.0% of the company's outstanding shares. The filing indicates that Leviticus Partners LP has sole voting and dispositive power over these shares. The filing was made under...

Kayne Anderson Capital Advisors, L.P. has filed a Schedule 13G with the SEC, reporting beneficial ownership of 11.41% of the common units of Mach Natural Resources LP. The filing indicates that Kayne Anderson Capital Advisors, L.P. manages accounts that hold 19,187,581 units, with sole voting and dispositive power over...

Clal Insurance Enterprises Holdings Ltd (Clal) has filed a Schedule 13G indicating its ownership in Gilat Satellite Networks Ltd. Clal beneficially owns 4,154,120 ordinary shares, which represents 7.3% of the total outstanding shares. Of these, 70,000 shares are held for Clal's own account, while the remaining 4,084,12...

CVI Investments, Inc. and Heights Capital Management, Inc. have filed a Schedule 13G indicating beneficial ownership of 9.9% of Bionano Genomics, Inc.'s common stock. The filing details the ownership of 1,021,671 shares, which includes shares issuable upon the exercise of warrants. Heights Capital Management, Inc. serv...

Alumni Capital LP, along with Alumni Capital GP LLC and Ashkan Mapar, filed a Schedule 13G on September 22, 2025, disclosing beneficial ownership of 9.58% of Aethlon Medical Inc.'s common stock. The filing indicates that Alumni Capital LP holds 781,110 shares, which includes shares that may be acquired through a Securi...

Squadron Master Fund LP, Squadron Capital Management, LLC, Matthew Sesterhenn, and William Blank have filed a Schedule 13G with the SEC regarding their ownership in Traws Pharma, Inc. The filing indicates that Squadron Master Fund LP owns 5.3% of the common stock, while Squadron Capital Management, LLC, Matthew Sesterh...

Jane Street Group, LLC, along with its subsidiaries Jane Street Capital, LLC, Jane Street Options, LLC, and Jane Street Global Trading, LLC, filed a Schedule 13G with the SEC regarding their holdings in Strive, Inc. The filing indicates that Jane Street Group, LLC beneficially owns 37,024,026 shares of Class A Common S...

Tontine Capital Overseas Master Fund II, L.P. (TCOM II), along with Tontine Asset Associates, LLC (TAA) and Jeffrey L. Gendell, has reported a 5.1% ownership in Smart Sand, Inc. The filing, made under Rule 13d-1(c), indicates that TCOM II directly owns 2,212,223 shares of Common Stock. TAA, as the general partner of TC...